Filing Details

Accession Number:
0001179110-12-016126
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-16 06:54:20
Reporting Period:
2012-11-15
Filing Date:
2012-11-16
Accepted Time:
2012-11-16 06:54:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360886 Osiris Therapeutics Inc. OSIR Biological Products, (No Disgnostic Substances) (2836) 710881115
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008317 Peter Friedli C/O Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia MD 21046
Yes No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-11-15 625 $9.34 4,656,051 No 4 S Indirect See Note 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Note 2
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,616,794 Direct
Footnotes
  1. Represents the sale of 625 shares of common stock by the Reporting Person's mother.
  2. The Reporting Person holds indirect beneficial ownership of 4,153,301 shares of common stock held by Venturetec, Inc., 500,000 shares held by his minor daughter and 2,750 shares held by his spouse. The Reporting Person holds approximately a 3% interest in Venturetec, Inc. and serves as its president. The Reporting Person disclaims beneficial ownership in the shares held by his daughter and spouse and disclaims beneficial interest in the shares held by Venturetec, Inc., beyond the extent of his pecuniary interest therein.